Delivery Order SPE2DB24D1021-SPE2DB25FEYXK
- Not listed
- The Defense Logistics Agency awarded a $1,358.05 delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Adacel TDAP vaccine in 0.5 mL vials. The contract is classified as a firm fixed-price delivery order with an ultimate completion date of July 15, 2025, and represents a non-competitive set-aside award. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $2,281.17 to AmerisourceBergen Drug Corp for ADACEL TDAP vaccine vials (0.5mL) on July 28, 2025, with a completion date of July 29, 2025. This firm fixed-price, non-competitive delivery order was issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. AmerisourceBergen, a major pharmaceutical distributor headquartered in...
- The Defense Logistics Agency awarded a $5,772.33 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ADACEL TDAP vaccine vials (0.5ml) on August 21, 2025, with completion targeted for August 22, 2025. This non-competitive delivery order leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.999 billion prime contract vehicle (SPE2DX) running through December 2026 that provides comprehensive pharmaceutical and medical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ADACEL TDAP Syringe 0.5ML with a ceiling value of $20,770.00 under a firm fixed-price contract type. The award was made on August 26, 2025, with an ultimate completion date of August 27, 2025. This delivery order represents a non-set-aside competitive award, with performance to be completed at the contractor's facility in Conshohocken, Pennsylvania. The ADACEL TDAP vaccine is a combination immunization...
- The U.S. Department of Defense's Medical Supply Chain awarded a $1,072.00 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Adacel TDAP syringes (5-pack unit). This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order with an ultimate completion date of July 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The Adacel TDAP vaccine delivery supports the Department of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ADACEL TDAP Syringe 0.5ML on September 12, 2025, with a ceiling value of $16,221.54 and firm fixed pricing. This non-set-aside, competitively awarded contract represents a child delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a $46,590.02 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ADACEL TDAP syringes (0.5mL) with an ultimate completion date of July 28, 2025. This competitively awarded, non-set-aside delivery order represents a single transaction under AmerisourceBergen's larger contract vehicle with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,729.52, is for the delivery of Adacel TDAP vaccine vials (0.5 ml) to support military healthcare programs. The contract has a period of performance through February 19, 2025 and uses a firm fixed-price pricing structure. This delivery order is part of a larger Indefinite Delivery...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ADACEL TDAP VIAL 0.5ML, a vaccine product, with a ceiling value of $4,062.68 and a performance period through June 2025. The contract is a firm-fixed-price delivery order and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- The Defense Logistics Agency awarded a $15,084.90 delivery order to AmerisourceBergen Drug Corp for Adacel TDAP syringes (0.5mL) on May 14, 2025, with completion scheduled for May 15, 2025. This non-set-aside contract employs firm fixed-price pricing and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a routine medical supply procurement under AmerisourceBergen's existing federal contract framework with the Defense Logistics...
- SPE2DB24D1021Indefinite Delivery Contract
- SPE2DB24D1021-SPE2DB25FEYXKDelivery Order
This delivery order, awarded July 22, 2025, by the Defense Logistics Agency to AmerisourceBergen Drug Corp, provides for the supply of ADACEL TDAP vaccine vials (0.5mL) with a ceiling value of $1,229.35. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of July 23, 2025. This delivery order is a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, leverages this comprehensive IDC vehicle to supply pharmaceutical products and medical commodities to support military healthcare programs globally. The ADACEL TDAP vaccine delivery supports the Defense Health Agency and other federal healthcare systems' immunization requirements. As a critical vendor within the federal medical supply chain, AmerisourceBergen Drug Corp has demonstrated capability to meet federal procurement requirements through multiple competitive contract awards with DLA, spanning diverse pharmaceutical categories including specialty medications, vaccines, and medical devices across various therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 7/22/25 |